88 related articles for article (PubMed ID: 14513041)
41. Influence of killer immunoglobulin-like receptor/HLA ligand matching on achievement of T-cell complete donor chimerism in related donor nonmyeloablative allogeneic hematopoietic stem cell transplantation.
Sobecks RM; Ball EJ; Askar M; Theil KS; Rybicki LA; Thomas D; Brown S; Kalaycio M; Andresen S; Pohlman B; Dean R; Sweetenham J; Macklis R; Bernhard L; Cherni K; Copelan E; Maciejewski JP; Bolwell BJ
Bone Marrow Transplant; 2008 Apr; 41(8):709-14. PubMed ID: 18195688
[TBL] [Abstract][Full Text] [Related]
42. A pilot study of reduced intensity conditioning and allogeneic stem cell transplantation from unrelated cord blood and matched family donors in children and adolescent recipients.
Del Toro G; Satwani P; Harrison L; Cheung YK; Brigid Bradley M; George D; Yamashiro DJ; Garvin J; Skerrett D; Bessmertny O; Wolownik K; Wischhover C; van de Ven C; Cairo MS
Bone Marrow Transplant; 2004 Mar; 33(6):613-22. PubMed ID: 14730337
[TBL] [Abstract][Full Text] [Related]
43. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.
Lisini D; Zecca M; Giorgiani G; Montagna D; Cristantielli R; Labirio M; Grignani P; Previderè C; Di Cesare-Merlone A; Amendola G; Bergami E; Mastronuzzi A; Maccario R; Locatelli F
Haematologica; 2008 Dec; 93(12):1859-67. PubMed ID: 18945748
[TBL] [Abstract][Full Text] [Related]
44. Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation.
Griffith LM; McCoy JP; Bolan CD; Stroncek DF; Pickett AC; Linton GF; Lundqvist A; Srinivasan R; Leitman SF; Childs RW
Br J Haematol; 2005 Mar; 128(5):668-75. PubMed ID: 15725089
[TBL] [Abstract][Full Text] [Related]
45. Analysis of donor NK and T cells infused in patients undergoing MHC-matched allogeneic hematopoietic transplantation.
Pascal V; Brunet C; Pradel V; Thirion X; Andre P; Faucher C; Sampol J; Dignat-George F; Blaise D; Vivier E; Chabannon C
Leukemia; 2002 Nov; 16(11):2259-66. PubMed ID: 12399971
[TBL] [Abstract][Full Text] [Related]
46. Clinical utility of chimerism status assessed by lineage-specific short tandem repeat analysis: experience from four cases of allogeneic stem cell transplantation.
Goh RY; Cho SS; Song YJ; Heo K; Oh SY; Kim SH; Kwon HC; Kim HJ; Han JY
Korean J Lab Med; 2009 Aug; 29(4):277-81. PubMed ID: 19726887
[TBL] [Abstract][Full Text] [Related]
47. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM
J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139
[TBL] [Abstract][Full Text] [Related]
48. Long-term immune recovery of patients undergoing allogeneic stem cell transplantation: a comparison with their respective sibling donors.
Sanchez-Guijo FM; Sanchez-Abarca LI; Bueno C; Villaron E; Lopez-Holgado N; Vazquez L; Lopez-Fidalgo J; Perez-Simon JA; Caballero MD; del Cañizo MC; Orfao A; San Miguel JF
Biol Blood Marrow Transplant; 2005 May; 11(5):354-61. PubMed ID: 15846289
[TBL] [Abstract][Full Text] [Related]
49. Risk for cytomegalovirus infection following reduced intensity allogeneic stem cell transplantation.
Nachbaur D; Larcher C; Kircher B; Eibl G; Nussbaumer W; Gunsilius E; Haun M; Grünewald K; Gastl G
Ann Hematol; 2003 Oct; 82(10):621-7. PubMed ID: 12920570
[TBL] [Abstract][Full Text] [Related]
50. Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children.
Bader P; Hölle W; Klingebiel T; Handgretinger R; Benda N; Schlegel PG; Niethammer D; Beck J
Bone Marrow Transplant; 1997 Apr; 19(7):697-702. PubMed ID: 9156247
[TBL] [Abstract][Full Text] [Related]
51. Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia.
Savani BN; Mielke S; Adams S; Uribe M; Rezvani K; Yong AS; Zeilah J; Kurlander R; Srinivasan R; Childs R; Hensel N; Barrett AJ
Leukemia; 2007 Oct; 21(10):2145-52. PubMed ID: 17673900
[TBL] [Abstract][Full Text] [Related]
52. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N
Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798
[TBL] [Abstract][Full Text] [Related]
53. Relapse after bone marrow transplantation: evidence for distinct immunological mechanisms between adult and paediatric populations.
Guimond M; Busque L; Baron C; Bonny Y; Bélanger R; Mattioli J; Perreault C; Roy DC
Br J Haematol; 2000 Apr; 109(1):130-7. PubMed ID: 10848792
[TBL] [Abstract][Full Text] [Related]
54. OKT-3-based reconditioning regimen for early graft failure in HLA-non-identical stem cell transplants.
Schlegel PG; Eyrich M; Bader P; Handgretinger R; Lang P; Niethammer D; Klingebiel T
Br J Haematol; 2000 Nov; 111(2):668-73. PubMed ID: 11122120
[TBL] [Abstract][Full Text] [Related]
55. Analysis of chimaerism in thalassaemic children undergoing stem cell transplantation.
Amrolia PJ; Vulliamy T; Vassiliou G; Lawson S; Bryon J; Kaeda J; Dokal I; Johnston R; Veys P; Darbyshire P; Roberts IA
Br J Haematol; 2001 Jul; 114(1):219-25. PubMed ID: 11472371
[TBL] [Abstract][Full Text] [Related]
56. Detection of mixed chimaerism in flow-sorted cell subpopulations by PCR-amplified VNTR markers after allogeneic bone marrow transplantation.
van Leeuwen JE; van Tol MJ; Bodzinga BG; Wijnen JT; van der Keur M; Joosten AM; Tanke HJ; Vossen JM; Khan PM
Br J Haematol; 1991 Oct; 79(2):218-25. PubMed ID: 1958479
[TBL] [Abstract][Full Text] [Related]
57. The significance of mixed chimaerism and cell lineage chimaerism monitoring in paediatric patients post haematopoietic stem cell transplant.
Kricke S; Rao K; Adams S
Br J Haematol; 2022 Aug; 198(4):625-640. PubMed ID: 35421255
[TBL] [Abstract][Full Text] [Related]
58. Human experimental chimaerism: Chimaeras as a source of stem cells.
Gardner RL
Reprod Biomed Online; 2002; 5(2):103. PubMed ID: 12419031
[No Abstract] [Full Text] [Related]
59. Immune Cell Lineage-Specific Chimerism Testing by Next-Generation Sequencing for Engraftment Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation.
Wu C; Dela Cruz T; Lai J; Kong D; Rajalingam R
Methods Mol Biol; 2023; 2621():187-213. PubMed ID: 37041446
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
